🔴 FluoGuide is trading 6.29% down today amid widening Q2 losses and cash burn

FluoGuide is trading at SEK 31.30, down -6.29%, as investors reassess valuation against ongoing losses and funding needs.

• Its August 25, 2026 Q2 report highlighted positive CT-005 Phase 2 results and FDA-authorized CT-006 progress.
• Q2 net loss widened to DKK 12.819 million, while cash declined to DKK 49.824 million by June 30.
• Operating cash flow remained negative, with no formal financial or cash-runway guidance provided.